DHA sttr phase II medical r & d contract from proposal no. H2-0403 titled,"oxygen production and delivery on demand".

Ended Definitive Contract Awarded Last action

Contract number
W81XWH19C0040
Awardee
Awarding agency
Obligated
$2,499,421

Award facts

Opportunity
  • HQ003418RBBDT Solicitation number
Contract value 100% obligated
$2,499,421.41 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Columbus, OH 43228, USA
Research
STTR Phase II
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00006 · Medical research and development phase II pivot plus up funding reobligation due to WBS error $1,499,999
Other Administrative Action P00005 · Medical research and development phase II pivot plus up modification to deobligate subclin 000301 and 000401 due to LOA error. Reobligation will occur via… -$1,499,999
Supplemental Agreement for work within scope P00004 · Medical research and development phase II pivot plus up $1,499,999
Supplemental Agreement for work within scope P00003 · Medical research and development DHA sttr PH II H2-0403 year 1 modification for section 889 requirements $0
Other Administrative Action P00002 · Medical research and development DHA sttr PH II H2-0403 year 1 for project titled oxygen production and delivery on demand $0
Supplemental Agreement for work within scope P00001 · Medical research and development DHA sttr PH II H2-0403 year 1 $499,422
Original award $500,000

About this award

This is a Firm Fixed Price STTR Phase II research and development contract awarded by the Department of Health Affairs (DHA) to Global Research & Development Inc., a small disadvantaged business. The contract, valued at $2,499,421.41, is for a project titled "Oxygen Production and Delivery on Demand" and is scheduled to be completed by April 2, 2023. The contract was awarded under the DHA's Medical R&D program and is focused on developing advanced membrane technologies for on-demand oxygen production and delivery. Global Research & Development Inc. has previously received grants from the Department of Energy for research into specialized membranes for gas separation, indicating their expertise in this area. This STTR Phase II contract builds on their prior work and aims to deliver innovative solutions to support military medical and logistics operations.

Quick answers

Who was awarded contract W81XWH19C0040?

W81XWH19C0040 was awarded to Global Research & Development Inc. by Medical Command (Department of the Army) on March 4, 2019.

How much is contract W81XWH19C0040 worth?

The government has obligated $2,499,421 on W81XWH19C0040.

Was contract W81XWH19C0040 competed?

The extent of competition for W81XWH19C0040 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award